国药新冠疫苗列入世卫紧急使用清单
世卫总干事谭德塞表示,将国药新冠疫苗列入世卫紧急使用清单。
他指,疫苗满足世卫组织有关新冠疫苗安全性、有效性及其质量的标准。世卫建议18岁以上接种2剂国药新冠疫苗。
另外,科兴公司研制的一款新冠疫苗也已进入世卫组织紧急使用授权评估的最後阶段。
日前,世卫专家点名中国两款国产疫苗国药及科兴疫苗的临床测试数据存疑,尤其是科兴疫苗对60岁或以上人士产生严重副作用风险低的测试结果,可信度非常低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.